ENTITY

Tg Therapeutics (TGTX US)

Health CareUnited States
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies, specifically, relapsed and refractory non-Hodgkins lymphoma.
more
Refresh
Company Event01 May 2024 20:30 • Latest
Company Event28 Feb 2024 21:30
Company Event01 Nov 2023 20:30
Company Event01 Aug 2023 20:30
Company Event01 May 2023 20:30
x